✦ LIBER ✦

A phase I study of MTA (multi-targeted antifolate, LY231514) plus cisplatin (CIS) in patients with advanced solid tumours

✍ Scribed by Thoedtmann, R.; Kemmerich, M.; Depenbrock, H.; Blatter, J.; Ohnmacht, U.; Rastetter, J.; Hanauske, A.-R.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

768 - Phase II study of a multi-targeted

✍ M.C. Cripps; M. Bumell; J. Jolivet; W. Lofters; B. Fisher; L. Panasci; J. Igiesi 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 263 KB

A phase I study of sequential gemcitabin

✍ A. Adjei; C. Erlichman; H. Pitot; J. Sloan; R. Goldberg; P. Peethambaram; L. Han 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 138 KB

A phase I study of the multitargeted ant

✍ Fumoleau, P.; Gamelin, E.; Misset, J.-L.; Delaloge, S.; Ripoche, V.; Kayitalire, 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 130 KB

A phase I study of pemetrexed (LY231514)

✍ Nakagawa, K; Kudoh, S; Matsui, K; Negoro, S; Yamamoto, N; Latz, J E; Adachi, S; 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 123 KB

A phase I study of OGT 719 in patients w

✍ Cassidy, J.; Carmichael, J. 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 277 KB

Phase I study of cisplatin, irinotecan,

✍ Chen, X; Oza, A M; Kusenda, Z; Yi, Q-L; Kochman, D; Moore, M J; Davis, A J; Siu, 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 127 KB